HYLORIS PHARMACEUTICALS SA (HYL.BR) Stock Analyst Ratings

Europe • Euronext Brussels • EBR:HYL • BE0974363955

7.76 EUR
-0.22 (-2.76%)
Last: Feb 2, 2026, 10:45 AM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to HYL.BR. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 13.84. This target is 78.33% above the current price.
  • HYL.BR was analyzed by 7 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HYL.BR.
  • In the previous month the buy percentage consensus was at a similar level.
  • HYL.BR was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

HYL.BR Historical Analyst RatingsHYL.BR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -59 -53 -47 -41 -35 -29 -23 -17 -11 -5 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 7.766.0614.5913.8421.42 - -21.91% 87.96% 78.33% 176.03%

Related screens

HYL.BR Current Analyst RatingHYL.BR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-12-22 KBC SECURITIES Maintains Buy -> Buy

HYLORIS PHARMACEUTICALS SA / HYL.BR FAQ

What is the price target for HYL stock?

7 analysts have analysed HYL.BR and the average price target is 13.84 EUR. This implies a price increase of 78.32% is expected in the next year compared to the current price of 7.76.


What is the consensus rating for HYLORIS PHARMACEUTICALS SA (HYL.BR) stock?

The consensus rating for HYLORIS PHARMACEUTICALS SA (HYL.BR) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for HYL stock?

The number of analysts covering HYLORIS PHARMACEUTICALS SA (HYL.BR) is 7.